Mitral valve prolapse and thromboembolic events

Israel Medical Association Journal

Volumn 3, Issue 4, 2001, Pages 282-283

  Blum, Arnon ^a   Shapira, Yami ^a   Yeganh, Shay ^a   Rabinkov, Maya ^a  

^a Poriya Hospital   (Israel)

Author keywords

Cerebral emboli; Mitral valve prolapse; Thromboembolic phenomena

Indexed keywords

FIBRINOPEPTIDE A; THROMBOCYTE FACTOR 4; VON WILLEBRAND FACTOR;

BRAIN EMBOLISM; CARDIOVASCULAR RISK; DEATH; DISEASE MARKER; ENDOCARDITIS; HUMAN; MITRAL VALVE PROLAPSE; PATHOGENESIS; REVIEW; STROKE; SURVIVAL; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; INTRACRANIAL EMBOLISM; MALE; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE PROLAPSE; SEX DISTRIBUTION;

EID: 0035003949     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (3)

1. Devereux RB. Recent developments in the diagnosis and management of mitral valve prolapse. Curr Opin Cardiol 1995;10:107-16.
2. Pocock WA. Mitral leaflet billowing and prolapse. In: Barlow JB, eds. Perspectives on the Mitral Valve. Philadelphia: F.A. Davis Co., 1987:45-112.
3. Perloff JK, Child JS, Edwards JE. New guidelines for the clinical diagnosis of mitral valve prolapse. Am J Cardiol 1986;57:1124-9.